Delivery Order SPE2DB20D1100-SPE2DB25FE4U4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,322.94 to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhaler (4 grams) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,917.50 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was awarded without a set-aside designation through open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4-gram quantities, with a ceiling value of $1,277.09. This firm fixed-price delivery order, which must be completed by August 15, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,042.65 delivery order to AmerisourceBergen Drug Corp for Spiriva Respimat 1.25 mcg inhalation medication (4 gm) with an ultimate completion date of August 1, 2025. This competitive award, utilizing firm fixed pricing, was issued with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,318.54 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Spiriva Respimat 2.5 mcg inhaler cartridges (4 grams). This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,652.46 to AmerisourceBergen Drug Corp for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This non-set-aside, firm fixed-price delivery order was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 2.5 MCG inhalation medication in a 4 GM formulation, with a ceiling value of $1,779.64. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.40 to AmerisourceBergen Drug Corp for Spiriva Respimat 2.5 mcg inhalation medication (4 grams) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a $4,865.00 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gram quantities. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing relationship with DLA. The pharmaceutical product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,787.88 to AmerisourceBergen Drug Corp for SPIRIVA RESPIMAT 1.25 MCG inhalation medication in 4-gram quantities. This competitively awarded, non-set-aside contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and operates under firm fixed pricing terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4U4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Spiriva Respimat 2.5 mcg inhalation medication in 4 gm units. This firm fixed price delivery order, valued at $2,640.52, is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is scheduled for completion by September 5, 2025, with performance at the company's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying medications and medical supplies to military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's prime IDC vehicle with DLA valued at $999,999,999.00 and extending through December 2026, which provides comprehensive global pharmaceutical support for military healthcare programs. The IDC enables the company to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The delivery order reflects the company's ongoing role as a preferred pharmaceutical vendor supporting the Defense Health Agency and other federal healthcare systems through flexible contract mechanisms designed to meet evolving military medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/4/25 |